Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Operating lease liabilities | (17,836) | (45,690) |
| Net cash used in operating activities | (200,459) | (248,552) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Purchases of property and equipment | (1,888) | (974) |
| Proceeds from sale of property and equipment | 90 | - |
| Purchases of marketable securities | (267,358) | (138,809) |
| Sales and maturities of marketable securities | 193,894 | 341,021 |
| Net cash (used in) provided by investing activities | (75,262) | 201,238 |
Item 1. Financial Statements
FAQ
- What is Intellia Therapeutics's capex?
- Intellia Therapeutics (NTLA) reported capex of $1.81M in Q2 2026.
- How has Intellia Therapeutics's capex changed year-over-year?
- Intellia Therapeutics's capex increased by 656.9% year-over-year, from $239K to $1.81M.
- What is the long-term trend for Intellia Therapeutics's capex?
- Over 4 years (2021 to 2025), Intellia Therapeutics's capex has grown at a -45.5% compound annual growth rate (CAGR), from $12.76M to $1.13M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Intellia Therapeutics's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude